From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. Editor's Picks

HIV/AIDS Editor's Picks

SUMMARY AND COMMENT

Testing Midstream Urine for Chlamydia trachomatis

Midstream samples might be adequate for evaluating both chlamydial and urinary tract infections, but study results were not definitive.

SUMMARY AND COMMENT

High-Dose Antivirals Do Not Fully Suppress Reactivation of Genital Herpes Simplex

Suppressive therapy is not adequate for preventing transmission.

SUMMARY AND COMMENT

New Antivirals Show Promise for an Interferon-Free Hepatitis C Treatment

Patients with HCV genotype 1 and previous null response achieved a 36% sustained virologic response at 24 weeks of therapy with daclatasvir and asunaprevir alone.

SUMMARY AND COMMENT

Effective Short-Course Treatment for Latent Tuberculosis

Three months of isoniazid plus rifapentine worked as well as 9 months of isoniazid.

CLINICAL PRACTICE GUIDELINE WATCH

Recommendations for Use of Short-Course Isoniazid-Rifapentine for Latent TBFree

This two-drug regimen, administered weekly for just 12 weeks, is efficacious in preventing active disease in patients with latent Mycobacterium tuberculosis infection.

SUMMARY AND COMMENT

Low Vitamin D Levels Linked to Active TuberculosisFree

Seasonal declines in mean vitamin D levels were followed by seasonal increases in TB notifications.

SUMMARY AND COMMENT

Quantitative PCR for Differentiating Between Pneumocystis Colonization and Infection

A newly developed strategy allowed definitive characterization of 96% of the samples evaluated.

SUMMARY AND COMMENT

HPV Vaccine Beneficial in Men Who Have Sex with MenFree

A quadrivalent HPV vaccine significantly reduced the rate of anal intraepithelial neoplasia in this high-risk population. Interview

SUMMARY AND COMMENT

Should We Continue Entecavir for HBV Infection Despite Partial Virologic Response?

Results from a prospective cohort study found continued virologic response without viral resistance to entecavir despite PVR for up to 3 years. CME

SUMMARY AND COMMENT

RTS,S/AS01 Vaccine Reduces Malaria Incidence by HalfFree

Initial results from a phase III trial show protection against clinical and severe malaria during the 12 months after vaccination in children aged 5 to 17 months.

Read more HIV/AIDS Editor's Picks articles >>

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

Browse arrow

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2012. Massachusetts Medical Society. All rights reserved.